Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug. They ...

Clinical trials are underway or completed for at least seven Alzheimer’s vaccines designed to harness the immune system to rid the brain of the disease-related proteins beta amyloid or tau, a ...

Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a ...

California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug.

University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to ...

UNM health scientists are seeking funding from the Alzheimer's Association and other venture capitalists to launch phase 1 of ...

Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...

- Commonly used Alzheimer's clinical trial exclusion criteria have the potential to disproportionately affect African Americans and Hispanics/Latinos, ...

In clinical trials for Alzheimer’s drugs, genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.

Weight loss jabs may offer a protective effect against dementia and stroke, according to a new study.People with type 2 diabetes and obesity who are taking the drugs are also less likely to die ...

A significant challenge in developing therapy and care for Alzheimer’s disease that work for people of different ethnic and racial backgrounds is recruitment and retention of traditionally ...